-
Signing up to DR Congo peace is one thing, delivery another
-
'Amazing' figurines find in Egyptian tomb solves mystery
-
Palestinians say Israeli army killed man in occupied West Bank
-
McLaren will make 'practical' call on team orders in Abu Dhabi, says boss Brown
-
Norris completes Abu Dhabi practice 'double top' to boost title bid
-
Chiba leads Liu at skating's Grand Prix Final
-
Meta partners with news outlets to expand AI content
-
Mainoo 'being ruined' at Man Utd: Scholes
-
Guardiola says broadcasters owe him wine after nine-goal thriller
-
Netflix to buy Warner Bros. Discovery in deal of the decade
-
French stars Moefana and Atonio return for Champions Cup
-
Penguins queue in Paris zoo for their bird flu jabs
-
Netflix to buy Warner Bros. Discovery for nearly $83 billion
-
Sri Lanka issues fresh landslide warnings as toll nears 500
-
Root says England still 'well and truly' in second Ashes Test
-
Chelsea's Maresca says rotation unavoidable
-
Italian president urges Olympic truce at Milan-Cortina torch ceremony
-
Norris edges Verstappen in opening practice for season-ending Abu Dhabi GP
-
Australia race clear of England to seize control of second Ashes Test
-
Trump strategy shifts from global role and vows 'resistance' in Europe
-
Turkey orders arrest of 29 footballers in betting scandal
-
EU hits X with 120-mn-euro fine, risking Trump ire
-
Arsenal's Merino has earned striking role: Arteta
-
Putin offers India 'uninterrupted' oil in summit talks with Modi
-
New Trump strategy vows shift from global role to regional
-
World Athletics ditches long jump take-off zone reform
-
French town offers 1,000-euro birth bonuses to save local clinic
-
After wins abroad, Syria leader must gain trust at home
-
Slot spots 'positive' signs at struggling Liverpool
-
Eyes of football world on 2026 World Cup draw with Trump centre stage
-
South Africa rugby coach Erasmus extends contract until 2031
-
Ex-Manchester Utd star Lingard announces South Korea exit
-
Australia edge ominously within 106 runs of England in second Ashes Test
-
McIlroy survives as Min Woo Lee surges into Australian Open hunt
-
German factory orders rise more than expected
-
Flooding kills two as Vietnam hit by dozens of landslides
-
Italy to open Europe's first marine sanctuary for dolphins
-
Hong Kong university suspends student union after calls for fire justice
-
Asian markets rise ahead of US data, expected Fed rate cut
-
Nigerian nightlife finds a new extravagance: cabaret
-
Tanzania tourism suffers after election killings
-
Yo-de-lay-UNESCO? Swiss hope for yodel heritage listing
-
Weatherald fires up as Australia race to 130-1 in second Ashes Test
-
Georgia's street dogs stir affection, fear, national debate
-
Survivors pick up pieces in flood-hit Indonesia as more rain predicted
-
Gibbs runs for three TDs as Lions down Cowboys to boost NFL playoff bid
-
Pandas and ping-pong: Macron ending China visit on lighter note
-
TikTok to comply with 'upsetting' Australian under-16 ban
-
Hope's resistance keeps West Indies alive in New Zealand Test
-
Pentagon endorses Australia submarine pact
Rare bone-eroding disease ruining lives in Kenya's poorest county
Joyce Lokonyi sits on an upturned bucket, fingers weaving palm fronds as the wind pulls her dress to expose the stump of her amputated foot, lost to a little-known disease ravaging Kenya's poorest county.
Mycetoma is a fungal or bacterial infection that enters the body through any open wound, often as tiny as a thorn prick.
Starting as tiny bumps under the skin, it gradually leads to the erosion of tissue, muscles and bone.
The fungal variety is endemic across the so-called "mycetoma belt" -- including Somalia, Sudan, Yemen and northern Kenya -- with funding and research desperately lacking.
Once the disease has reached the bone the only option is amputation.
"I was able to slightly walk, although the disease had eaten all my toes," Lokonyi, 28, told AFP.
She was shunned by the local community, she said.
"They used to say that when you go to someone's home, you will leave traces of the disease where you stand."
She was unable to afford medication despite her husband selling off his goats, and amputation became the only option.
"I accepted because I saw that it was going to kill me," she said, a pair of battered crutches lying on the sand beside her two-year-old daughter.
But she has struggled with the aftermath.
"I have become a good-for-nothing, I can't work, I can't burn charcoal, I can't do anything," she said.
- Neglected -
In Kenya's poorest county, Turkana, around 70 percent of the population lives beneath the poverty line, with healthcare limited and hard to reach.
Mycetoma disproportionately affects rural communities of farmers and herders, according to the Drugs for Neglected Diseases initiative (DNDi), a global NGO.
It was only recognised as a neglected disease by the World Health Organization in 2016. Ignorance and misdiagnosis remain widespread.
"Doctors are not aware of the disease," Borna Nyaoke-Anoke, DNDi's head of mycetoma research, told AFP.
"If you're used to donkeys, you don't start seeing zebras everywhere."
The scale of the problem is difficult to estimate, but Ekiru Kidalio, director of Lodwar Hospital in Turkana, said they "rarely go a week without finding a case".
He added that the local population, 80 percent of which is illiterate, often turns to traditional medicine.
By the time they come to hospital "the condition is already advanced such that it's not easy to reverse".
Medication is also expensive -- treatment takes up to a year and costs as much as $2,000 -- and comes with dizzying side effects.
Diagnosis and treatment are not free under Kenya's overwhelmed health system, leaving patients at the mercy of foreign donors or seeking sums that are unimaginable for subsistence farmers.
- 'Think about the worst' -
In Lodwar Hospital, lab technician John Ekai bends over his microscope and examines a suspected mycetoma sample.
"Mycetoma is a very neglected disease, no-one is giving it attention," he told AFP.
He has become the go-to man for suspected patients, handling his charges with a mischievous sense of humour that puts them at ease.
Ekai has treated more than 100 mycetoma patients in the past year, but has seen only five recoveries, with many simply vanishing back into Turkana's arid plains.
He worries for those who have disappeared: "The mycetoma will grow and grow and maybe... lead to amputation."
During AFP's visit, he examined young mother Jennifer Ekal, 19, who had lived with the disease since she was 11.
"I was in school but I decided to leave because of my foot," she said, showing her swollen and painful extremity, hidden beneath a red-and-white dishcloth.
Four doses of medication a day appeared to be helping, she said.
But as she gathered up her daughter, three-year-old Bianca, she admitted she was worried about the future.
"I do not want to think about the worst."
S.Caetano--PC